A Japanese health ministry proposal to impose steeper price cuts on certain medicines deemed to carry poor cost-effectiveness profiles cleared…
HOME > REGULATORY
REGULATORY
- Number of Diseases Eligible for Medical Aid Would Increase to Over 300 Under New Proposal
November 1, 2012
- RMP to Be Made Available through the Internet During Review Stage: Director Tawaragi of PFSB
October 30, 2012
- MHLW Earmarks 200 Mil. Yen for Drug Quality Assurance and Development of New Vaccine Quality Test Methods as Part of Emergency Economic Measures
October 30, 2012
- Japan Adopts Emergency Economic Package, 3.8 Billion Yen Front-Loaded for iPS Research, Drug Discovery Support
October 30, 2012
- PAFSC’s 1st Committee Recommends Approval for Pfizer’s OAB Drug Toviaz
October 29, 2012
- DPJ Vice President Sengoku Says JMA “Paranoid” over TPP Concerns
October 29, 2012
- Keidanren, JCCI Call for Expansion of R&D Tax Break System at Tax Commission Hearings
October 29, 2012
- Number of Pharmacies in Japan Rises to 54,780 as of FY2011 End: MHLW
October 29, 2012
- MHLW Unveils Action Plan for 5-Year Clinical Trial Activation Plan
October 26, 2012
- MHLW to Initially Limit Number of Stores to Offer Epadel OTC
October 26, 2012
- US Paperwork Reduction Act Will Not Affect ICH PBRER Guidelines: MHLW
October 26, 2012
- BBPD to Seek Reductions in Market Prices of Domestic Blood Products: New BBPD Director Kato
October 26, 2012
- Basic Bill for Regenerative Medicine to Be Submitted to Extraordinary Diet by Bipartisan Lawmaker-Initiated Legislation
October 26, 2012
- METI and MEXT Call for Increase in R&D Tax Credit
October 25, 2012
- Generic-Only Requirement for People on Welfare “Would Be Problematic”: Health Minister Mitsui
October 24, 2012
- MOF Asks Committee to Discuss Mandatory Generic Drug Use for People on Welfare
October 24, 2012
- MHLW Project to Study Generic Evaluation Criteria Gets Underway
October 23, 2012
- Health Minister Mitsui Pledges Seamless Support for New Drug Development
October 22, 2012
- Sales Tax Hike Expected to Hasten Separation of Dispensing from Medical Practice by Sapping Yakka-Saeki
October 19, 2012
- FSA to Determine Whether Infertility Treatment Should Be Covered by Private Insurers
October 19, 2012
ページ
A Japanese drug pricing panel on November 11 discussed ways to respond to the US most-favored-nation (MFN) policy, with healthcare…
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…